Pharmala Biotech Holdings Company Description

Pharmala Biotech Holdings Inc., doing business as PharmAla, engages in the development, manufacture and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community.

The company offers its MDMA drug active pharmaceutical ingredient under the LaNeo brand name. Pharmala Biotech Holdings Inc. is headquartered in Vancouver, Canada.

Pharmala Biotech Holdings Inc.

Country	Canada
Industry	Biotechnology
Sector	Healthcare
CEO	Nicholas Kadysh

Contact Details

Address: 1055 West Georgia Street Vancouver, British Columbia V6E 4N7 Canada
Website	pharmala.ca

Stock Details

Ticker Symbol	MDMA
Exchange	Canadian Securities Exchange
Reporting Currency	CAD
ISIN Number	CA71719L1067
SIC Code	2833

Key Executives

Name	Position
Nicholas Kadysh	Director, President and Chief Executive Officer
Dr. Shane Morris Ph.D.	Chief Operating Officer
Harpreet Kaur	Vice President of Research
William Avery C.A., CPA	Chief Financial Officer
Ali Taghva	Chief Commercial Officer